# Presentation: 552941

## Slide 1

## Overview of 1st 

**172 days... **

**10 hours... **

**14 minutes... **

**(*****but who’s counting?*****)**

## William Corrigall, Ph.D.  -  Chief, TRB, DNBR and

** ****Director, Nicotine and Tobacco Addiction Program  **

**Ron A. Dobbins ****- CCTN**

**Susan E. Martin, Ph.D.**** – DESPR**

**Dawn Rabunsky ****– OPRM, CMB**

**Dave Daubert ****– OPRM, MASB**

**Charlotte Annan ****– OD/SPO**

**Redonna Chandler, Ph.D. ****– DESPR**

**Bev Pringle, Ph.D.**** – DESPR**

## Dr. Ahmed Elkashef  -  Physician Research of the

**   ****Year Award from PHS Commissioned Corps  **

**Diana Haikalis ****– Letter of Appreciation**

**Debra Battle-Dudley**** – Letter of Appreciation**

**Daisey Parker ****– Letter of Appreciation**

**Deborah Wertz ****– Special Recognition Award**

## Slide 5

## Slide 6

## Slide 7

## National Prevention Research Initiative (NPRI)

**National Prevention Research Initiative (NPRI)**

## Slide 9

## 21 Applications

**Issued: February 4, 2002**
**Application Receipt Date: May 13, 2002**

**21 Applications**

## Slide 11

## Slide 12

## Slide 13

## Slide 14

## Slide 15

## Summary:

***Summary*****:**
** ****Prevention principles**
** ****Frequently**
**    ****asked questions**
** ****Epidemiology**
** ****NIDA’s major**
**    ****research programs**

## Slide 17

## Press Conference Participants (Mar. 13, 2002):

**Press Conference Participants (Mar. 13, 2002):**

**NIDA – Dr. David Shurtleff**
**ONDCP – John Walters**
**SAMHSA – Charles Curie**
**CSAT – Westley Clark**
**CSAP – Elaine Parry**
**Partnership for a Drug Free America – Stephen Pasierb**
**National Inhalant Prevention Coalition – Harvey Weiss**

## Slide 19

## Slide 20

## Slide 21

## Slide 22

## Educational loan repayment programs (LRP)

**Educational loan repayment programs (LRP)**
**for Clinical, Pediatric, Contraceptive and**
**Infertility, and Health Disparities Researchers**
**from a Disadvantaged Background **

## (NIDA-26; NIH- >600)

**Regarding Clinical Researchers**

**Purpose:**** ****Recruitment and retention**** of highly**
**qualified ****health professionals as clinical investigators****;**
***Participants contractually agree to engage in clinical***
***research as extramural grantees or awardees***

**Provides for the repayment of up to ****$35,000**** of**
**awardees’ loans for each year of obligated service**

**(NIDA-26; NIH- >600)**

## Slide 25

## Slide 26

## EIC

**EIC**
**NIDA**
**RWJ**

**Sponsored by:**

## Slide 28

## Meetings Continued

** ****Enhancing Outcomes in Women’s Health**

## Objective:

***Objective*****:**
** ****-enhance practical use**
**   ****of research and **
**   ****rapid adaptation into**
**   ****drug abuse treatment**

## What Is Changing at NIDA?

**NORMAL Redefined**

## TRANSLATION & ACCOUNTABILITY

***TRANSLATION & ACCOUNTABILITY***

## Slide 33

## TEST  SCIENCE

**Goal: to decrease drug abuse by **
**10% in 2 yrs. & 25% in 5 yrs.**

**TEST  SCIENCE**

**MOVE SCIENCE INTO**
**COMMUNITIES**

**DO  SCIENCE**

## Slide 35

## Slide 36

## Slide 37

**Notes:**
I will be talking about these areas of science because we are both excited about these particular research areas and for the most part we are proposing new initiatives in these areas fro FY03 and FY04we are proposing  Not all these areas involve RFAs so please don’t get nervous.

## Slide 38

## Slide 39

## Slide 40

## Slide 41

## Slide 42

## Future 

**Directions**

**We Want **
**FEEDBACK****!**

## Slide 44

## Slide 45